95 related articles for article (PubMed ID: 9178166)
21. Transgenic animal models of familial amyotrophic lateral sclerosis.
Gurney ME
J Neurol; 1997 May; 244 Suppl 2():S15-20. PubMed ID: 9178166
[TBL] [Abstract][Full Text] [Related]
22. Pathogenic mechanisms in familial amyotrophic lateral sclerosis due to mutation of Cu, Zn superoxide dismutase.
Gurney ME; Cutting FB; Zhai P; Andrus PK; Hall ED
Pathol Biol (Paris); 1996 Jan; 44(1):51-6. PubMed ID: 8734301
[TBL] [Abstract][Full Text] [Related]
23. The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies.
Gurney ME
J Neurol Sci; 1997 Oct; 152 Suppl 1():S67-73. PubMed ID: 9419057
[TBL] [Abstract][Full Text] [Related]
24. [Familial amyotrophic lateral sclerosis and mutations in the Cu/Zn superoxide dismutase gene].
Nakano R
Rinsho Shinkeigaku; 1995 Dec; 35(12):1546-8. PubMed ID: 8752459
[TBL] [Abstract][Full Text] [Related]
25. Lack of involvement of neuronal nitric oxide synthase in the pathogenesis of a transgenic mouse model of familial amyotrophic lateral sclerosis.
Facchinetti F; Sasaki M; Cutting FB; Zhai P; MacDonald JE; Reif D; Beal MF; Huang PL; Dawson TM; Gurney ME; Dawson VL
Neuroscience; 1999; 90(4):1483-92. PubMed ID: 10338314
[TBL] [Abstract][Full Text] [Related]
26. The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu,Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease.
Mourelatos Z; Gonatas NK; Stieber A; Gurney ME; Dal Canto MC
Proc Natl Acad Sci U S A; 1996 May; 93(11):5472-7. PubMed ID: 8643599
[TBL] [Abstract][Full Text] [Related]
27. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis.
Gurney ME; Cutting FB; Zhai P; Doble A; Taylor CP; Andrus PK; Hall ED
Ann Neurol; 1996 Feb; 39(2):147-57. PubMed ID: 8967745
[TBL] [Abstract][Full Text] [Related]
28. Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Chiu AY; Zhai P; Dal Canto MC; Peters TM; Kwon YW; Prattis SM; Gurney ME
Mol Cell Neurosci; 1995 Aug; 6(4):349-62. PubMed ID: 8846004
[TBL] [Abstract][Full Text] [Related]
29. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury.
Reaume AG; Elliott JL; Hoffman EK; Kowall NW; Ferrante RJ; Siwek DF; Wilcox HM; Flood DG; Beal MF; Brown RH; Scott RW; Snider WD
Nat Genet; 1996 May; 13(1):43-7. PubMed ID: 8673102
[TBL] [Abstract][Full Text] [Related]
30. A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: An enhancement of free radical formation due to a decrease in Km for hydrogen peroxide.
Yim MB; Kang JH; Yim HS; Kwak HS; Chock PB; Stadtman ER
Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5709-14. PubMed ID: 8650157
[TBL] [Abstract][Full Text] [Related]
31. Potential treatment of amyotrophic lateral sclerosis with gabapentin: a hypothesis.
Welty DF; Schielke GP; Rothstein JD
Ann Pharmacother; 1995 Nov; 29(11):1164-7. PubMed ID: 8573965
[TBL] [Abstract][Full Text] [Related]
32. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis.
Wiedau-Pazos M; Goto JJ; Rabizadeh S; Gralla EB; Roe JA; Lee MK; Valentine JS; Bredesen DE
Science; 1996 Jan; 271(5248):515-8. PubMed ID: 8560268
[TBL] [Abstract][Full Text] [Related]
33. Altered metabolism of excitatory amino acids, N-acetyl-aspartate and N-acetyl-aspartyl-glutamate in amyotrophic lateral sclerosis.
Plaitakis A; Constantakakis E
Brain Res Bull; 1993; 30(3-4):381-6. PubMed ID: 8457887
[TBL] [Abstract][Full Text] [Related]
34. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.
Rosen DR; Siddique T; Patterson D; Figlewicz DA; Sapp P; Hentati A; Donaldson D; Goto J; O'Regan JP; Deng HX
Nature; 1993 Mar; 362(6415):59-62. PubMed ID: 8446170
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
